PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
9.66%
Net income growth similar to MCHP's 9.14%. Walter Schloss would find parallel expansions or market conditions in both firms’ profitability.
6.25%
Some D&A expansion while MCHP is negative at -3.16%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-429.63%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
No Data
No Data available this quarter, please select a different quarter.
19.31%
Well above MCHP's 33.39% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
917.24%
AR growth while MCHP is negative at -235.21%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-37.88%
Both reduce yoy inventory, with MCHP at -3.73%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
No Data
No Data available this quarter, please select a different quarter.
-59.76%
Negative yoy usage while MCHP is 2674.54%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-633.33%
Negative yoy while MCHP is 1968.37%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-6.68%
Negative yoy CFO while MCHP is 7.04%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
23.99%
Some CapEx rise while MCHP is negative at -2.70%. John Neff would see competitor possibly building capacity while we hold back expansions.
-137.29%
Negative yoy acquisition while MCHP stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-16.25%
Negative yoy purchasing while MCHP stands at 56.41%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
12.63%
We have some liquidation growth while MCHP is negative at -23.98%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
No Data
No Data available this quarter, please select a different quarter.
17.22%
Lower net investing outflow yoy vs. MCHP's 129.61%, preserving short-term cash. David Dodd would confirm expansions remain sufficient.
No Data
No Data available this quarter, please select a different quarter.
600.00%
Stock issuance far above MCHP's 86.40%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
No Data
No Data available this quarter, please select a different quarter.